Table 1.
Patients’ characteristics
| Characteristic | No. of patients (%) |
|---|---|
|
Sex |
|
| Male |
30 (78.9) |
| Female |
8 (21.1) |
|
Age, y |
|
| Median [range] |
62 [27–81] |
|
ECOG performance status |
|
| 0 |
25 (65.8) |
| 1 |
7 (18.4) |
| > 1 |
6 (15.8) |
|
MSKCC risk category |
|
| Favorable |
8 (21.1) |
| Intermediate |
20 (52.6) |
| Poor |
10 (26.3) |
|
Target organs |
|
| Lung |
31 (81.6) |
| Liver |
6 (15.8) |
| Lymph node |
11 (28.9) |
| Kidney |
15 (39.5) |
|
Nephrectomy |
|
| Yes |
30 (78.9) |
| No (biopsy) |
8 (21.1) |
|
Prior treatments |
|
| None |
27 (71.1) |
| Cytokines alone |
4 (10.5) |
| Sorafenib ± cytokines | 7 (18.4) |